Skip to content
Free trial
Download PDF

Pharmaceuticals and Healthcare

Companies in the pharmaceutical and healthcare sector face numerous challenges to their global growth, as they seek to expand into high-reward / high-risk emerging markets. These risks encompass corruption, unauthorised copying of patented medicines and competition from manufacturers of low-cost generic drugs, alongside broader operational and reputational risks related to irregular legal and regulatory environments and fast-changing political risks.

Maplecroft has developed a range of products and services to enable pharmaceutical and healthcare companies to identify, monitor and manage these risks throughout their value chains and to pinpoint market opportunities. These include sector specific country risk reports; over 200 risk indices and interactive maps; risk screening tools to assess supply chain risks; and company risk reports, developed to enable due diligence on suppliers; and a suite of interactive risk calculators and dashboards that draw on Maplecroft’s global risks analytics and which can be tailored to suit a company’s specific risk appetite.

Visit Maplecroft’s Global Risks Portfolio to see full details of available products, including risk indices, maps and country scorecards, as well as in-depth reports that can be tailored to the pharmaceuticals and healthcare sector. Alternatively register for free trial access.

  • 01
  • 02
  • 03

Pharmaceuticals and Healthcare

01Analysing primary risks to the pharmaceuticals industry in key emerging markets

Maplecroft has recently produced a series of country risk reports on key fast-growing pharmaceutical and healthcare markets, including China, Brazil and Mexico, for a well-known multinational pharmaceutical company.

Each report focused on one country and provided:

  • In-depth summary of the status of the healthcare sector and infrastructure in that country.
  • Detailed assessment of key regulatory issues faced by the country’s pharmaceutical industry.
  • Comprehensive review of proposed healthcare reform and implications for the pharmaceutical sector.

Additional follow-up reports were then produced for selected countries, which the client had identified as being of exceptional interest. These follow-up reports included more tightly targeted analysis on key issues of concern, such as supply chain integrity and transparency, access to healthcare and product security. The reports additionally outlined key steps that the client could take to manage and mitigate these risks.

Pharmaceuticals and Healthcare

02Creation of an Interactive Risk Dashboard for a global producer of pharmaceuticals

Maplecroft has developed an online Interactive Risk Dashboard™ to enable a multinational pharmaceutical company to monitor risk issues across its value chain - including investments, operations, supply chain, and distribution networks.

  • Utilising Maplecroft’s bank of 200 risk indices and interactive maps the Interactive Risk Dashboard™ enables the client to choose and focus on the issues and territories that are most relevant to them to identify hotspots of risk within its value chain.
  • By adding their own risk and compliance data the Dashboard enables the company to create a single risk knowledge centre, where company resources are securely stored alongside, and are used in tandem with Maplecroft’s research.
  • The company uses the Dashboard to develop ‘custom’ groupings to aggregate indices and apply simple weightings to calculate new indices, which are specific to the unique risks facing the pharmaceutical sector. They view risk outputs on the Dashboard via indices, interactive maps and tailored scorecards.

The Interactive Risk Dashboard™ allows the company to identify risks that are specific to them across selected countries or regions. It highlights cross-linkages between issues, countries and departments, while also linking to horizon outlooks and other issues to enable them to manage risks across their entire value chain.

Pharmaceuticals and Healthcare

03Analysing and mapping global dietary deficiencies for a leading vitamin producer and an intergovernmental organisation

Maplecroft was contracted by a multinational leader in micronutrients and food fortification, in association with an intergovernmental organisation, to produce a series of global indices and maps to identify which countries’ populations were at most risk of malnutrition and dietary deficiencies.

  • Maplecroft developed a suite of indices and interactive maps for the company, covering hunger; accumulative micronutrient and vitamin deficiency; iron deficiency; vitamin A deficiency; and GDP losses due to micronutrient and vitamin deficiency.
  • The indices and maps highlighted the populations most exposed to vitamin deficiencies and hunger across 200 countries and the data was used to inform food aid programs for the intergovernmental organisation.
  • A campaign by the company raising public awareness of the issue was also instigated, with Maplecroft’s communications team working with the international press to exploit PR opportunities.
  • The interactive maps, hosted by Maplecroft, were embedded in the company’s website and made publically available, as part of their corporate responsibility programme.